Autoimmune hemolytic anemia (AIHA) is an acquired hemolytic disorder, mediated by auto-
antibodies, and has a variable clinical course ranging from fully compensated low grade …

Autoimmune hemolytic anemia is a rare condition characterized by destruction of red blood
cells with and without involvement of complement. It is associated with significant morbidity …

Patients with relapsed warm antibody autoimmune hemolytic anemia (wAIHA) have limited
treatment options. Fostamatinib is a potent, orally administered spleen tyrosine kinase …

Warm antibody autoimmune hemolytic anemia (wAIHA) is characterized by hemolysis and
symptomatic anemia with no approved treatment options. Fostamatinib is an oral spleen …

Background: Warm autoimmune haemolytic anaemia (wAIHA) is a haemolytic disorder, most
commonly seen among adults and is classified as either primary or secondary to an …

This retrospective cohort study described real-world treatment patterns and healthcare
resource utilization (HCRU) of patients with warm autoimmune hemolytic anemia (wAIHA) …

Objective We performed a systematic review and meta‐analysis to evaluate the efficacy and
safety of therapeutic plasma exchange (TPE) in adult patients with autoimmune hemolytic …

Background Immune hemolytic anemia commonly affects human immune deficiency
infected individuals. Among anemic HIV patients in Africa, the burden of IHA due to …

Autoimmune hemolytic anaemia (AIHA) is an uncommon cause of antibody-induced
hemolytic anemia in children. This is divided into three categories warm AIHA, cold antibody …

Аутоиммунная гемолитическая анемия-редкое заболевание, характеризующееся
появлением антиэритроцитарных аутоантител и последующим разрушением …